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INTRODUCTION
Propofol (2,6-diisopropylphenol) is a substituted isopropyl-
phenol compound that causes a depression in consciousness.
1 
Propofol is thought to be a relatively safe intravenous anesthet-
ic, and rare cases of anaphylaxis following propofol administra-
tion have been reported in the medical literature.
2 Here we re-
port a patient who experienced an anaphylactic reaction with 
severe oropharyngeal edema and bronchospasm for 1 minute 
after receiving propofol during endoscopic examination. The 
case was confirmed by an allergic skin test to be a type I hyper-
sensitive reaction with oropharyngeal angioedema and bron-
chospasm, due to repeat exposure to propofol.
 
CASE REPORT
A previously healthy 74-year-old woman, 143 cm in height 
and 49 kg in weight, visited our hospital to undergo esophago-
gastroduodenoscopy (EGD) for a check-up. She experienced 
abdominal discomfort to soybean without skin lesion and asth-
ma, but she had no other remarkable medical history including 
allergy. An EGD procedure using 15 mg propofol was performed 
twice in this patient prior to this admission without any side ef-
fects. Her initial blood pressure (BP) was 130/70 mmHg and 
heart rate was regular, ranging from 80 to 90 beats per minute. 
A Case of Propofol-Induced Oropharyngeal Angioedema and 
Bronchospasm
Byung-Chul You, An-Soo Jang,* Ji-Su Han, Hong-Woo Cheon, Jong-Suk Park, June-Hyuk Lee, Sung-Woo Park,  
Do-Jin Kim, Choon-Sik Park
Division of Allergy and Respiratory Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
We did not use lidocaine for oropharyngeal anesthesia, and all 
of the medical team involved in her exam used vinyl gloves. 
Under standard monitoring, sedation was induced with 15 mg 
intravenous propofol (Propofol Inj., Jeil Pharm, Seoul, Korea). 
The patient was then sedated and we began the exam. Approxi-
mately 1 minute following administration of intravenous pro-
pofol, stridor was heard and oxygen saturation fell to 56% on 
pulse oximetry. We immediately applied inhaled oxygen (6 L/
min) via nasal prong, but oxygen saturation did not increase. 
We decided to stop the exam, and tried to remove the endo-
scope. However, the endoscope became stuck in her throat. 
Thus, we removed the endoscope by compulsion. Ten seconds 
after endoscope removal, severe wheezing was heard and her 
oxygen saturation fell to 56%. The larynx was observed using a 
laryngoscope for endotracheal intubation. At that time, marked 
swelling and severe edema of the epiglottis extending to the ar-
ytenoids cartilage was detected. Epinephrine (1 mg) was im-
Case Report
Allergy Asthma Immunol Res. 2012 January;4(1):46-48.
http://dx.doi.org/10.4168/aair.2012.4.1.46
pISSN 2092-7355 • eISSN 2092-7363
Propofol (2,6-diisopropylphenol) is an ultrashort-acting sedative agent with sedative and amnestic effects that is used not only for anesthesia but 
also for sedation during minor outpatient procedures and endoscopic examinations. Rare cases of anaphylaxis following propofol administration 
have been reported in the medical literature. Documentation of anaphylaxis is often lacking because the cause and effect relationship is often hard 
to prove. Only a minority of patients get referred for allergy testing to confirm the offending drug. Here we report a 74-year-old woman who had an 
anaphylactic reaction with severe oropharyngeal edema and bronchospasm for a few minutes after receiving propofol during endoscopic examina-
tion. An allergy skin test was positive for both propofol and soybean. Soybean in the intralipid is one component of propofol, and we concluded that 
this anaphylaxis was caused by soybean.
Key Words:  Bronchial spasm; angioedema; anaphylaxis; propofol
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits 
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Correspondence to:  An-Soo Jang, MD, PhD, Division of Allergy and 
Respiratory Medicine, Soonchunhyang University Bucheon Hospital, 
Soonchunhyang University College of Medicine, 1174 Jung-dong, Wonmi-gu, 
Bucheon 420-767, Korea.
Tel: +82-32-621-5114; Fax: +82-32-621-5018; E-mail: jas877@schmc.ac.kr
Received: July 26, 2011; Accepted: October 14, 2011
•There are no financial or other issues that might lead to conflict of interest.A Case of Propofol-Induced Anaphylaxis
Allergy Asthma Immunol Res. 2012 January;4(1):46-48.  http://dx.doi.org/10.4168/aair.2012.4.1.46
AAIR 
47 http://e-aair.org
mediately administered subcutaneously, together with 125 mg 
intravenous methylprednisolone infusion. Because the patient’s 
symptoms did not improve after 1 minute, 1 mg epinephrine 
was administered intravenously. After a further 1 minute, her 
oxygen saturation recovered to 98% and the wheezing subsid-
ed. The patient’s BP never went below 130/70 mmHg during 
the event. She recovered smoothly from anesthesia without 
signs of airway obstruction and was transferred to the general 
ward. Blood samples were drawn immediately after the event. 
Tryptase level (normal range, 0-13.5 μg/L) was 4.65 μg/L at 5 
minutes and 6.61 μg/L at 2 hours. Arterial blood gas analysis 
showed pH 7.404, pCO2 42.5 mmHg, pO2 119.6 mmHg, HCO3
- 
26 mEq/L, and SaO2 98.3%. Total IgE was 111 kU/L. The patient 
underwent skin-prick testing 14 days after the event. The skin-
prick tests of 55 common inhalant allergens were negative. How-
ever, propofol and 20% intralipid (SMOFlipid
®, Fresenius Kabi, 
Bad Homburg, Germany) showed an immediate reaction (Ta-
ble). Thus, we suspected the soybean in intralipid, a compo-
nent of propofol, as the cause of the anaphylaxis, because she 
had a food allergy history to soybean. She was informed of the 
results and of the risk for anaphylaxis if re-exposed to propofol 
or nutritional supplements containing soybean in the future.
DISCUSSION
The most common drugs that trigger IgE-mediated anaphy-
laxis are neuromuscular blocking agents and antibiotics, in-
cluding penicillin and cephalosporins, during the perioperative 
period.
2 Neuromuscular blocking agents are involved in peri-
operative IgE-mediated anaphylaxis in 50-70% of cases accord-
ing to epidemiological studies.
2-5
Propofol is an alkylphenol derivative (2,6-diisopropylphenol) 
marketed as an oil water emulsion using soybean oil (10%), and 
egg lecithin (1.2%) as the emulsifying agent. Lecithin is a highly 
purified phosphatide found in egg yolk, but is not the allergenic 
determinant.
6 Five major allergens, Gal d 1-5, have been char-
acterized in hen eggs.
7 Chicken serum albumin (Gal d 5) is the 
major allergen in egg yolk.
8 There is no confirmed report of pro-
pofol-induced anaphylaxis by allergy testing in egg-allergic pa-
tients.
9,10
The formulation of propofol as well as its active component 
contain soybean oil. Soy allergy is one of the most common food 
allergies in childhood, affecting approximately 0.4% of presch-
ool children. It is considered an early-onset food allergy with 
most patients developing soy tolerance by late childhood.
11 Soy 
allergy is occasionally present during adulthood. Refined soy 
oil, such as that present in propofol, is safe for people with soy 
allergy because the allergenic proteins are removed during the 
refining process. Thus, it is unlikely that the soy oil present in 
propofol will induce allergy, as the dose of protein contained in 
refined soy oil is too small to provoke a reaction.
12 The few doc-
umented IgE-mediated anaphylactic reactions to propofol have 
been shown to be elicited by the isopropyl or phenol groups 
rather than the lipid vehicle.
13,14
Although IgE-mediated anaphylactic reactions to propofol are 
rare, the incidence of allergic reaction during anesthesia is in 
the range of 1:10,000 to 1:20,000, and 1.2% of cases of perioper-
ative anaphylactic shock are attributable to propofol.
15 For this 
reason, the product was reformulated as an emulsion contain-
ing soybean oil and purified egg phosphatide (extracted from 
egg yolk) to reduce allergenicity. Propofol allergy is often attrib-
uted to the presence of a diisopropyl side chain or phenol group 
or soybean rather than to egg allergy.
13 Allergic reactions to pro-
pofol on first exposure are usually due to the isopropyl groups 
that may act as epitopes and that are present in various medi-
cations and cosmetics.
14 Allergic reactions to propofol upon re-
exposure are usually due to the phenol molecule.
16,17
In Korea, Shin et al.
18 and Chung et al.
19 reported anaphylaxis 
after exposure to propofol, but they could not determine which 
component caused the anaphylaxis, and their patients experi-
enced anaphylaxis after first propofol exposure. In this case, we 
proved through skin-prick testing, without increasing tryptase 
level, that the soybean component of propofol was an impor-
tant cause of anaphylaxis during an anesthetic procedure. To 
the best of our knowledge, this is the first case report of anaphy-
laxis after re-exposure to propofol in Korea. Referral of these 
cases to an allergy clinic is important for subsequent anesthetic 
exposure.
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